Key market opportunities for mesenchymal stem cells include advancements in regenerative medicine, growing investments in R&D ...
FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company ...
Living tissues do not change through biology alone. They are shaped by a constant dialogue among forces, chemicals, and ...
Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); ...
Planning for dual launches of bezuclastinib in Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST)- Pivotal data from Phase 3 PEAK ...
Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...
Unlocking immunotherapy through stromal science. We are pleased to share a recent Global ImmunoTalk featuring GCIR Professor Stéphanie Hugues, who presented he ...
R3 Stem Cell's trademark for "Regenerative Trifecta" formalizes the brand identity of a clinical protocol used across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results